ABCL — AbCellera Biologics Inc. price, chart and key statistics

Price data

Price

$11.37

YTD price return

+232.46%

YTD total return

+232.46%

Next earnings

Nov 9, 2026 · After close

Market cap

3.5B2020-12 10.8B2026-10 3.5B-67.8% over the window

Enterprise value

3.1B

Shares outstanding

306.6M2019-12 151.3M2026-06 306.6M+102.6% over the window

52W low

$2.75

52W high

$15.02

From 52W high

-24.28%

From 52W low

+314.21%

52W range

70%

Volume

Rel volume

0.83×

30D volume

5.1M

30D $ vol

65.3M

Fundamentals

Sales (ttm)

66.2M2019-12 11.6M2026-06 66.2M+469.9% over the window

Sales/share

$0.222019-12 $0.082026-06 $0.22+181.3% over the window

EPS (ttm)

-$0.552019-12 -$0.012026-06 -$0.55+5355.6% over the window

FCF (ttm)

-119.7M2019-12 -1.3M2026-06 -119.7M+9084.3% over the window

FCF/share

-$0.392019-12 -$0.012026-06 -$0.39+4432.9% over the window

Book value/share

$2.922019-12 $0.072026-06 $2.92+4213.6% over the window

Net margin

-248.83%2019-12 -19.0%2026-06 -248.8%+1206.8% over the window

ROE

-18.38%2019-12 -21.6%2026-06 -18.4%-14.8% over the window

ROA

-12.59%2020-12 11.8%2026-06 -12.6%-206.5% over the window

Current ratio

12.772020-12 7.862026-06 12.77+62.5% over the window

Growth (CAGR, ttm) · 10Y

Sales

+101.38%2025-06-30 → 2026-06-3032.9M → 66.2M (+101.3% total)-23.04%2023-06-30 → 2026-06-30145.2M → 66.2M (-54.4% total)-31.78%2021-06-30 → 2026-06-30447.7M → 66.2M (-85.2% total)n/a

Shares

+2.60%2025-06-30 → 2026-06-30298.8M → 306.6M (+2.6% total)+1.95%2023-06-30 → 2026-06-30289.4M → 306.6M (+6.0% total)+1.93%2021-06-30 → 2026-06-30278.7M → 306.6M (+10.0% total)n/a

Per-share growth (CAGR, ttm) · 10Y

Sales/share

+96.26%2025-06-30 → 2026-06-30$0.11 → $0.22 (+96.2% total)-24.51%2023-06-30 → 2026-06-30$0.50 → $0.22 (-57.0% total)-33.07%2021-06-30 → 2026-06-30$1.61 → $0.22 (-86.6% total)n/a

Book value/share

-13.29%2025-06-30 → 2026-06-30$3.37 → $2.92 (-13.3% total)-10.88%2023-06-30 → 2026-06-30$4.13 → $2.92 (-29.2% total)-3.39%2021-06-30 → 2026-06-30$3.47 → $2.92 (-15.8% total)n/a

Price

+107.97%2025-10-22 → 2026-10-22$5.47 → $11.37 (+107.9% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.+38.64%2023-10-23 → 2026-10-22$4.27 → $11.37 (+166.3% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.-6.57%2021-10-22 → 2026-10-22$15.97 → $11.37 (-28.8% total)Price appreciation from split-adjusted daily closes, excluding dividends; endpoints are exact trading-day anniversaries of the latest close.n/a

Total return

+107.97%2025-10-22 → 2026-10-22$5.47 → $11.37 (+107.9% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.+38.64%2023-10-23 → 2026-10-22$4.27 → $11.37 (+166.3% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.-6.57%2021-10-22 → 2026-10-22$15.97 → $11.37 (-28.8% total)Total return with dividends reinvested (adjusted daily closes); endpoints are exact trading-day anniversaries of the latest close. The gap against the Price row is the dividend contribution.n/a

Fundamentals end at the last reported quarter; price and total return end at the latest close.

Valuation

P/E (ttm)Price ÷ TTM diluted EPS. Net income carries everything below the operating line, including one-off gains. Negative when the trailing year lost money.

-20.8×2020-12 91.192026-10 -21.20-123.2% over the window

Fwd P/E

-15.5×

P/S (ttm)Market cap ÷ TTM revenue.

52.7×2020-12 46.512026-10 52.75+13.4% over the window

P/B (mrq)Market cap ÷ stockholders' equity at the most recent quarter end.

3.9×2020-12 13.062026-10 3.90-70.2% over the window

EV/Sales (ttm)

46.7×

FCF yield (ttm)TTM free cash flow ÷ market cap — the inverse of P/FCF.

-3.43%2020-12 0.1%2026-06 -5.0%-4242.2% over the window

Buyback yield (realized, 1y)1 − shares_at(2026-06-30) ÷ shares_at(2025-06-30) = 1 − 306.6M ÷ 298.8M. Point-in-time share counts from the company's own SEC filings (the same count at both ends), published only when the cash flow statement shows repurchases inside that window. A falling price can't inflate it; negative means net dilution.

-2.60%

Shareholder yield (realized, 1y)Buyback leg + dividend leg: shares retired over the year (-2.60%) + dividends paid over that year ($0) ÷ market_cap_at(2025-06-30) ($1B). Both legs are measured against the start of the window, so a payout can't shrink its own denominator.

-2.60%

Buyback yield (cash, ttm)Buybacks net of issuance over the trailing twelve months ($0) ÷ today's market cap ($3.5B). Dollars SPENT over what the company is worth NOW — a stock that fell after buying reads high.

0.00%2020-12 -4.8%2026-06 0.0%-100.0% over the window

Shareholder yield (cash, ttm)(TTM buybacks net of issuance $0 + TTM dividends $0) ÷ today's market cap ($3.5B). Same caveat as the cash buyback yield.

0.00%2020-12 -4.8%2026-06 0.0%-100.0% over the window

Vs own 10Y history

P/S

95th

P/B

80th